Quick Answer
CytoDyn Inc. reported Common Stock Shares Outstanding of 1.25 billion shares for the year ending 2025.
- CytoDyn Inc. showed an increase of +18.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from CytoDyn Inc.'s annual report (Form 10-K), filed with the SEC on July 25, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), CytoDyn Inc.'s Common Stock Shares Outstanding has grown by 5,503.9%.
- Historical annual values: Fiscal year 2025: 1.25 billion shares | Fiscal year 2024: 1.06 billion shares | Fiscal year 2023: 918.61 million shares | Fiscal year 2022: 719.59 million shares | Fiscal year 2021: 625.68 million shares | Fiscal year 2020: 518.98 million shares | Fiscal year 2019: 329.40 million shares | Fiscal year 2018: 216.72 million shares | Fiscal year 2017: 149.47 million shares | Fiscal year 2016: 123.34 million shares | Fiscal year 2015: 63.64 million shares | Fiscal year 2014: 55.75 million shares | Fiscal year 2013: 30.91 million shares | Fiscal year 2012: 28.64 million shares | Fiscal year 2011: 22.29 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: